AXXZIA INC

Company Overview

AXXZIA develops and sells own-brand skincare, eye-care products, beauty drinks, supplements and beauty devices. End customers are reached mainly through Chinese e-commerce and live-commerce platforms, supplemented by salons, retailers and Japanese e-commerce. China supplied 72.2% of FY2025 revenue, including 64.6% from Chinese e-commerce; other overseas markets remained only 2.4%. FY2026 revenue was ¥13.467 billion. At ¥300 on September 18, 2026, the equity was valued at ¥6.861 billion. The investment outcome depends on whether AXXZIA can again convert its high product gross margin into cash after advertising, platform commissions and payroll; the current price offers little protection if those costs are permanent.

How the Company Makes Money

Consumers pay for products such as AGTHEORY beauty drinks, AXXZIA Beauty Eyes sheets and premium skincare. AXXZIA differentiates through Japanese quality positioning, formulations tailored to Chinese consumers, regulatory registrations, rapid product launches and relationships with Chinese influencers and platforms. Mass production is largely outsourced, while an acquired factory handles smaller batches and development work. This historically produced gross margins near 79% in FY2023 and FY2024. Gross margin fell to 73.3% in FY2025 as lower-margin subsidiary M&D became a larger part of sales, but remained 73.9% in FY2026.

Most historical profit appears to have originated from China-facing own-brand sales, particularly e-commerce. Channel profit is not disclosed, but China generated nearly three-quarters of sales, while M&D’s Japanese distribution business was explicitly lower margin. The Shanghai subsidiary alone reported ¥2.978 billion of external revenue and ¥267 million of ordinary profit in FY2025.

The main constraint is customer acquisition rather than manufacturing cost. In FY2025, advertising consumed ¥3.467 billion, or 25.7% of revenue, and payment commissions another ¥2.025 billion, or 15.0%. Employee salaries and allowances took 7.7%. These costs left only a 3.8% operating margin despite a 73.3% gross margin. Chinese platforms, influencers and increasingly capable local brands can capture much of the product margin because AXXZIA must continually buy visibility. Growth also requires inventory—¥1.948 billion at FY2025—and capital spending of ¥326 million versus ¥160 million of depreciation. Higher sales therefore create value only when repeat purchases reduce advertising intensity.

Why the Stock Fell

The supplied data establishes a ¥300 price on September 18, 2026, but not a verified starting price, so no percentage share-price decline is claimed. The operating deterioration nevertheless explains the de-rating:

In FY2024, live-commerce advertising and influencer commissions drove operating profit down 51.7% despite 7.5% revenue growth. FY2025 revenue grew another 10.5%, partly through M&D, but its lower gross margin and additional employees reduced operating profit by 44.1%. In FY2026, revenue was flat and gross profit actually increased slightly, yet calculated selling and administrative costs rose about ¥767 million, or 8.2%, producing the operating loss. Management attributed this to Chinese e-commerce advertising and expanded staffing.

Forecast credibility also weakened. FY2026 initially carried guidance for ¥570 million of operating profit but finished with a ¥176 million loss. The company then recorded ¥410 million of impairments against fixed assets, M&D goodwill and overseas assets. FY2027 guidance calls for 9.9% revenue growth to ¥14.8 billion but another ¥50 million operating loss and ¥185 million net loss. The supplied six-year metrics tell the same story: revenue CAGR was 18.4%, while net-income CAGR was negative 22.1% and owner-earnings CAGR negative 50.6%.

What the Market Is Assuming

Conditional reverse valuation, using the September 18, 2026 price and FY2026 results: ¥300 multiplied by 22.8704 million diluted shares gives the supplied ¥6.861 billion market capitalization. FY2026 book value was ¥7.141 billion, or approximately ¥312 per share, making the price 0.96 times book. Supplied owner earnings were only ¥18.678 million, a 0.27% yield and a 367-year simple payback.

At a 12% required equity return and 2% perpetual growth, the market value requires about ¥686 million of sustainable annual distributable earnings. Assuming normalized non-operating income of zero, a 30% tax rate and ¥100 million of annual net reinvestment, FY2027 guided revenue of ¥14.8 billion would need an operating margin of approximately 7.6%. With no perpetual growth, the hurdle rises to about 8.9%.

At FY2026’s 73.9% gross margin, a 7.6% operating margin on ¥14.8 billion of sales permits selling and administrative expenses of approximately ¥9.81 billion. That is ¥313 million below FY2026 despite nearly 10% more revenue. The price therefore assumes both renewed sales growth and substantial advertising and payroll leverage after FY2027; meeting revenue guidance while remaining near break-even is insufficient.

Temporary or Structural?

The damage is mixed but predominantly ESSENCE. Chinese consumer weakness, periodic anti-Japanese sentiment and the decline in Chinese inbound travel after November are TIME factors. Product-level economics also remain viable: FY2026 gross margin held at 73.9%, showing no broad collapse in pricing or manufacturing economics.

The conversion of gross profit into shareholder cash has deteriorated structurally. Operating margin fell from 16.8% to negative 1.3% over three years while revenue increased 18.7%. Chinese local brands now compete for the same platform traffic, and live-commerce platforms and influencers charge for access to customers. AXXZIA’s brand and regulatory know-how have not prevented advertising from behaving like a second cost of goods sold. M&D then added lower-margin revenue, employees and ultimately impaired goodwill. The ¥410 million impairment confirms that part of the diversification capital failed to earn its carrying value.

Recovery requires advertising and commission costs to grow much more slowly than revenue, total selling and administrative expenses to remain around ¥10 billion as sales approach ¥15–16 billion, and Japanese or Southeast Asian growth to come from profitable own brands rather than low-margin distribution. The balance sheet can fund the attempt: FY2026 net assets were ¥7.141 billion, the equity ratio was about 80%, and operating cash flow remained positive at ¥298 million. There is no immediate survival or refinancing problem. However, the planned ¥10 dividend remains uncovered by forecast FY2027 earnings and would transfer roughly ¥229 million to shareholders while losses continue.

The strongest contrary evidence is that much of the cost increase was discretionary growth spending. Gross margin remains high, other Asian markets grew, and management could cut advertising or staffing. Nevertheless, three consecutive years of margin decline, another forecast loss and the impairment make a rapid return to old economics an assumption rather than an observed recovery.

Is the Market Wrong? By How Much?

The valuation uses equity owner earnings and does not add a separate net-cash balance because supplied net cash is n/a. The FY2026 bridge is:

Normalized distributable earnings are modeled as revenue multiplied by operating margin, less 30% tax and ¥100 million of recurring net reinvestment. That reinvestment assumption is below FY2025’s ¥166 million difference between capital expenditure and depreciation, allowing some recent spending to be growth-related. No stock-based compensation is added back, and the 22.8704 million diluted share count is used consistently; supplied FY2026 share-count change was 0.00%.

The asset cross-check is less reassuring than the low price-to-book ratio suggests. FY2025 NCAV was ¥5.554 billion, or approximately ¥243 per current share and 80.94% of the September 2026 market capitalization. That figure predates the FY2026 loss and cannot be updated because the detailed short-term securities and investment balances are unavailable. No defensible liquidation estimate or route to distribute the assets has been established. The FY2025 buyback shows some willingness to return capital, but the subsequent impairment shows that book value can also be consumed.

The evidence does not support a meaningful margin of safety at ¥300. The price protects against near-term financing failure but requires an outcome close to the bull case: high-single-digit margins restored within roughly two years. The assumption most capable of overturning this conclusion is a sharp, durable improvement in Chinese advertising efficiency combined with the return of surplus assets to shareholders.

Key Facts, Estimates, and Judgments